Lataa...
Sacubitril‐valsartan initiation in chronic heart failure patients impacts sleep apnea: the ENTRESTO‐SAS study
AIMS: Optimizing medical cardiac treatment for sleep apnoea (SA) in patients with chronic heart failure and reduced ejection fraction (HFrEF) is an expert Grade C recommendation based on six studies encompassing a total of 67 patients only. Whether sacubitril–valsartan (SV), a cornerstone of HFrEF m...
Tallennettuna:
| Julkaisussa: | ESC Heart Fail |
|---|---|
| Päätekijät: | , , , , , , , , , , , , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
John Wiley and Sons Inc.
2021
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8318447/ https://ncbi.nlm.nih.gov/pubmed/34102018 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ehf2.13455 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|